Oxford Immunotec: 2Q Earnings Snapshot
ABINGDON, Britain (AP) _ Oxford Immunotec Global PLC (OXFD) on Tuesday reported second-quarter net income of $590,000, after reporting a loss in the same period a year earlier.
On a per-share basis, the Abingdon, Britain-based company said it had profit of 2 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.
The immunology diagnostics company posted revenue of $19.6 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $19.4 million.
For the current quarter ending in October, Oxford Immunotec said it expects revenue in the range of $20 million to $21 million.
The company expects full-year revenue in the range of $71 million to $73 million.
Oxford Immunotec shares have climbed slightly since the beginning of the year. The stock has decreased 10% in the last 12 months.